Biochem/physiol Actions
SC-1 is a derivative of the multiple tyrosine kinase inhibitor sorafenib with no kinase-inhibition activity. SC-1 blocks STAT3 phosphorylation and activation with similar potency to sorafenib, and induces apoptosis in hepatocellular carcinoma cell lines.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: